F. K. Jansen

1.6k total citations
48 papers, 1.3k citations indexed

About

F. K. Jansen is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, F. K. Jansen has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 18 papers in Biotechnology and 10 papers in Molecular Biology. Recurrent topics in F. K. Jansen's work include Toxin Mechanisms and Immunotoxins (25 papers), Transgenic Plants and Applications (17 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). F. K. Jansen is often cited by papers focused on Toxin Mechanisms and Immunotoxins (25 papers), Transgenic Plants and Applications (17 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). F. K. Jansen collaborates with scholars based in France, Germany and United States. F. K. Jansen's co-authors include Pierre Casellas, Pierre Gros, Hubert Vidal, H. Blythman, Olivier Gros, B. Bourrié, Bernard Pau, F Paolucci, Bernard Bourrié and R Kinský and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

F. K. Jansen

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. K. Jansen France 18 972 652 498 355 108 48 1.3k
William Cushley United Kingdom 14 486 0.5× 173 0.3× 369 0.7× 188 0.5× 30 0.3× 44 899
B Bonavida United States 19 656 0.7× 49 0.1× 322 0.6× 102 0.3× 51 0.5× 53 997
William J. Grimes United States 19 315 0.3× 95 0.1× 738 1.5× 139 0.4× 144 1.3× 40 1.2k
Madiha Derouazi Switzerland 21 359 0.4× 113 0.2× 749 1.5× 90 0.3× 366 3.4× 35 1.2k
Catherine Kettleborough United Kingdom 15 270 0.3× 39 0.1× 610 1.2× 234 0.7× 44 0.4× 30 1.3k
E L Barsumian Japan 14 1.3k 1.3× 28 0.0× 642 1.3× 641 1.8× 46 0.4× 19 2.0k
Kazuhito Ohishi Japan 20 419 0.4× 66 0.1× 979 2.0× 42 0.1× 113 1.0× 30 1.7k
Stuart Kornfeld United States 13 225 0.2× 70 0.1× 956 1.9× 102 0.3× 84 0.8× 20 1.4k
Regina Voglauer Austria 17 316 0.3× 35 0.1× 562 1.1× 164 0.5× 64 0.6× 23 1.1k
Nicole Müller Germany 17 577 0.6× 37 0.1× 783 1.6× 96 0.3× 62 0.6× 33 1.3k

Countries citing papers authored by F. K. Jansen

Since Specialization
Citations

This map shows the geographic impact of F. K. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. K. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. K. Jansen more than expected).

Fields of papers citing papers by F. K. Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. K. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. K. Jansen. The network helps show where F. K. Jansen may publish in the future.

Co-authorship network of co-authors of F. K. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of F. K. Jansen. A scholar is included among the top collaborators of F. K. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. K. Jansen. F. K. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Åkerud, Tomas, Caterina Fusco, Peter Brandt, et al.. (2025). Mechanism and kinetics of turnover inhibitors of nicotinamide N-methyl transferase in vitro and in vivo. Journal of Biological Chemistry. 301(6). 108492–108492. 1 indexed citations
2.
3.
Gusek-Schneider, Gabriele C., et al.. (1999). Familiäre Katarakt bei Galaktitol-Erhöhung im Plasma ohne bekannten Enzymdefekt. Klinische Monatsblätter für Augenheilkunde. 215(10). 255–257. 1 indexed citations
4.
Carayon, P, A. Bord, J Gaillard, et al.. (1993). Ricin A-chain cytotoxicity depends on its presentation to the cell membrane. Bioconjugate Chemistry. 4(2). 146–152. 3 indexed citations
5.
Burlet, Arlette, F. K. Jansen, Frédérique Menzaghi, et al.. (1992). Long-term reduction of vasopressin excretion induced by the central injection of an immunoconjugate (antibody to vasopressin linked to ricin a chain). Neuroscience. 50(4). 965–973. 7 indexed citations
6.
Jansen, F. K., Jean‐Marie Derocq, Dominique Carrière, et al.. (1992). Golgi vacuolization and immunotoxin enhancement by monensin and perhexiline depend on a serum protein. Implications for intracellular trafficking.. Journal of Biological Chemistry. 267(18). 12577–12582. 11 indexed citations
7.
Shire, David, B. Bourrié, Christine Carillon, et al.. (1990). Biologically active A-chain of the plant toxin ricin expressed from a synthetic gene in Escherichia coli. Gene. 93(2). 183–188. 9 indexed citations
8.
Chiron, Marielle, Jean‐Marie Derocq, Emilienne Kühlein, et al.. (1989). Sensitivity of fresh leukemic cells to T101 ricin a-chain immunotoxin: A comparative study between Fab fragment and whole Ig conjugates. Leukemia Research. 13(6). 491–499. 3 indexed citations
9.
Derocq, Jean‐Marie, et al.. (1988). Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.. The Journal of Immunology. 141(8). 2837–2843. 29 indexed citations
10.
Casellas, Pierre & F. K. Jansen. (1988). Immunotoxin enhancers. Cancer treatment and research. 37. 351–369. 13 indexed citations
11.
Derocq, Jean‐Marie, Guy Laurent, Pascal Poncelet, et al.. (1987). RATIONALE FOR THE SELECTION OF RICIN A-CHAIN ANTI-T IMMUNOTOXINS FOR MATURE T CELL DEPLETION. Transplantation. 44(6). 763–769. 15 indexed citations
12.
Weil-Hillman, G, Walter Runge, F. K. Jansen, & Daniel A. Vallera. (1985). Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.. PubMed. 45(3). 1328–36. 32 indexed citations
13.
Vidal, Hubert, Pierre Casellas, Pierre Gros, & F. K. Jansen. (1985). Studies on components of immunotoxins: Purification of ricin and its subunits and influence of unreacted antibodies. International Journal of Cancer. 36(6). 705–711. 19 indexed citations
14.
Blythman, H., Pierre Casellas, G Laurent, & F. K. Jansen. (1985). Recent advances with immunotoxins. European Journal of Cancer and Clinical Oncology. 21(11). 1373–1373. 4 indexed citations
15.
Casellas, Pierre, Bernard Bourrié, Pierre Gros, & F. K. Jansen. (1984). Kinetics of Cytotoxicity Induced by Immunotoxins. 27 indexed citations
16.
Vexiau, P, I Deschamps, F. K. Jansen, J C Homberg, & J Hors. (1984). Detection of islet cell antibodies by a microcytotoxicity method. Journal of Immunological Methods. 68(1-2). 177–183. 1 indexed citations
17.
Kl�ppel, G., E. Alten�hr, G. Freytag, & F. K. Jansen. (1974). Immune insulitis and manifest diabetes mellitus. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 364(4). 333–346. 5 indexed citations
18.
Jansen, F. K., et al.. (1973). Insulin labelled by coupling with peroxidase. Diabetologia. 9(1). 53–55. 1 indexed citations
19.
Jansen, F. K.. (1971). Tolerance to high and low doses of natural crystalline insulin. Diabetologia. 7(4). 290–292. 5 indexed citations
20.
Jansen, F. K., et al.. (1965). Spektralphotometrische Bestimmung des Urans in Erzen und Kernbrennstoffen als Na4[UO2(CO3)3] bzw. K4[UO2(CO3)3]. Fresenius Zeitschrift für Analytische Chemie. 208(5). 332–333. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026